Compounds > lactic acid

lactic acid and risedronic acid

lactic acid has been researched along with risedronic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Shamy, A; Awad, GA; Mansour, S; Mortada, ND; Nasr, M1
Al Shamy, A; Awad, GA; Mansour, S; Mortada, ND; Nasr, M; Taha, I1
Ali, J; Baboota, S; Fazil, M; Hassan, MQ1
Ahmad, FJ; Gupta, S; Kalam, A; Manglani, K; Rawat, P; Talegaonkar, S; Vohora, D1
Abdel Hamid, MA; Elkasabgy, NA; Gawdat, SI; Kataia, MM; Mahmoud, AA; Shamma, RN1

Other Studies

5 other study(ies) available for lactic acid and risedronic acid

ArticleYear
A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres.
    Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:2

    Topics: Analysis of Variance; Bone Density Conservation Agents; Drug Compounding; Etidronic Acid; Lactic Acid; Microspheres; Models, Statistical; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risedronic Acid

2011
Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011, Volume: 79, Issue:3

    Topics: Administration, Inhalation; Animals; Biocompatible Materials; Bone and Bones; Bone Density Conservation Agents; Calorimetry, Differential Scanning; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Etidronic Acid; Humans; Lactic Acid; Lung; Male; Microscopy, Electron, Scanning; Microspheres; Osmotic Pressure; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Alveoli; Rats; Risedronic Acid; Sodium Chloride; Solubility; Surface Properties; Tissue Distribution

2011
Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis.
    Drug delivery, 2016, Volume: 23, Issue:7

    Topics: Administration, Intranasal; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Nanoparticles; Nasal Mucosa; Osteoporosis; Polyglycolic Acid; Risedronic Acid

2016
Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
    Pharmaceutical research, 2015, Volume: 32, Issue:10

    Topics: Animals; Bone and Bones; Chemistry, Pharmaceutical; Dexamethasone; Drug Carriers; Durapatite; Lactic Acid; Male; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tablets

2015
Design of novel injectable in-situ forming scaffolds for non-surgical treatment of periapical lesions: In-vitro and in-vivo evaluation.
    International journal of pharmaceutics, 2017, Apr-15, Volume: 521, Issue:1-2

    Topics: Animals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dogs; Injections; Lactic Acid; Male; Periapical Diseases; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risedronic Acid; Solubility; Sucrose; Tissue Scaffolds; Viscosity

2017